IndraLab

Statements


| 1

reach
"Upon treating JOSD2-depletion cells with proteasome inhibitor MG132, we demonstrated that the degradation of YAP/TAZ protein mediated by JOSD2 depletion was significantly attenuated (Fig. 2H)."